Vaccine-Specific Recommendations (by Date Published)

Consult the ACIP Recommendations page for a complete list of Morbidity and Mortality Weekly Reports (MMWR) on Recommendations of the Advisory Committee on Immunization Practices (ACIP) related to vaccines and immunizations.

Links to final CDC vaccination recommendations (published in MMWR) from Advisory Committee on Immunization Practices (ACIP)

Listed by Date Published

2017

• Meningococcal Vaccine
  Patton ME, Stephens D, Moore K, MacNeil JR. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
  Source: MMWR. 2017;66(19);509-13.
• Oral Cholera vaccine
  Wong KK, Burdette E, Mahon BE, Mintz ED, Ryan ET, Reingold AL. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
  Source: MMWR. 2017;66(18);482-5.
• Adult immunization schedule
  Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017
  Source: MMWR. 2017;66(5);136-8.
• Child/adolescent immunization schedule
  Robinson CL, Romero JR, Kempe A, Pellegrini C; Advisory Committee on Immunization Practices (ACIP) Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017
  Source: MMWR. 2017;66(5);134-5.

2016

• Human Papillomavirus vaccination
  Meites E, Kempe A, Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
  Source: MMWR. 2016;65(49);1405-8.
• Meningococcal conjugate vaccine
  MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IP, Martin SW. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016
  Source: MMWR. 2016;65(43);1189-94.
• Influenza vaccines (2016-17 season)
  Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2016–17 Influenza Season
  Source: MMWR. 2016;65(5);1-54.
• Smallpox vaccine
  Petersen BW, Harms TJ, Reynolds MG, Harrison LH. Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
  Source: MMWR. 2016;65(10);257-262.
• Child/adolescent immunization schedules
  Kim DK, Bridges CB, Harriman KH, Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016
  Source: MMWR. 2016;65(4);88-90.
• Adult immunization schedule
  Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016
  Source: MMWR. 2016;65(4);86-87.

2015

• Meningococcal vaccine
  MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
  Source: MMWR. 2015:64(41);1171-6
• DTaP vaccine
  Liang J, Wallace G, Mootrey G. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose
  Source: MMWR. 2015:64(34);948-949
• Influenza vaccines (2015-16 season)
  Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP – U.S., 2015-16 Influenza Season
  Source: MMWR. 2015:64(30);818-825
• PCV13 and PPSV23 vaccines
  Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the ACIP
  Source: MMWR. 2015;64(34):944-7
• Yellow Fever vaccine
  Staples JE, Bocchini JA, Rubin L, Fischer M. Use of Yellow Fever Vaccine Booster Doses
  Source: MMWR. 2015;64(23);647-650
• Serogroup B Meningococcal vaccine
  Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the ACIP, 2015
  Source: MMWR. 2015;64(22);608-612
• Typhoid vaccine
  Jackson BR, Iqbal S, Mahon B. Updated Recommendations for the Use of Typhoid Vaccine
  Source: MMWR. 2015;64(11);305-308
• HPV vaccine
  Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-Valent Human Papillomavirus (HPV) Vaccine
  Source: MMWR. 2015;64(11);300-304
• Child/adolescent immunization schedules
  Strikas RA, ACIP, ACIP Child/Adolescent Immunization Work Group. ACIP Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015
  Source: MMWR. 2015;64(04);93-94
• Adult immunization schedule
  Kim DK, Bridges CB, Harriman KH, ACIP, ACIP Adult Immunization Work Group. ACIP Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015
  Source: MMWR. 2015;64(04);91-92

Top of Page

2014

• Pneumococcal vaccines
  Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of PCV-13 and PPSV-23 vaccine among adults aged 65 and older: recommendations of the ACIP
  Source: MMWR. 2014;63(37);822-825
• HPV vaccine
  Human Papillomavirus Vaccination: Recommendations of the ACIP
  Source: MMWR; August 29, 2014 / 63(RR05);1-30
• Influenza vaccines (2014-15 season)
  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP – U.S., 2014-15 Influenza Season
  Source: MMWR; August 15, 2014 / 63(32);691-697
• Meningococcal vaccine
  Use of MenACWY-CRM Vaccine in Children Age 2 Through 23 Months at Increased Risk, Recommendations of the ACIP, 2013
  Source: MMWR; June 20, 2014 / 63(24);527-530
• Hib vaccine recommendations
  Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the ACIP, 2014
  Source: MMWR; February 28, 2014 / 63(RR01);1-14

Top of Page

2013

• JE vaccine for children
  Use of Japanese Encephalitis Vaccine in Children: Recommendations of the ACIP, 2013
  Source: MMWR; November 15, 2013 / 62(45);898-900
• Influenza vaccines (2013-14 season)
  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP—United States, 2013–2014
  Source: MMWR; September 20, 2013 / 62(RR07);1-43
• Updated recommendations for use of VariZIG
  Updated Recommendations for Use of VariZIG—United States, 2013
  Source: MMWR; July 19, 2013 / 62(28);574-576
• PCV13 and PPSV23 for ages 6-18 years with immuno. conditions
  Use of PCV-13 and PPSV-23 Vaccines Among Children Aged 6–18 Years with Immunocompromising Conditions
  Source: MMWR; June 28, 2013 / 62(25);521-524
• MMR and CRS
  Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP
  Source: MMWR; June 14, 2013 / 62(RR04);1-34
• Influenza interim recommendations
  Prevention and Control of Influenza with Vaccines: Interim Recommendations of ACIP, 2013
  Source: MMWR; May 10, 2013 / 62(18);356-356
• Meningococcal disease
  Prevention and Control of Meningococcal Diseases: Recommendations of ACIP
  Source: MMWR; March 22, 2013 / 62(RR02);1-22
• Tdap and pregnancy
  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women—ACIP, 2012
  Source: MMWR; February 22, 2013 / 62(07);131-135
• Infant meningococcal vaccination
  Infant Meningococcal Vaccination: ACIP Recommendations and Rationale
  Source: MMWR; January 25, 2013 / 62(03);52-54

2012

• PCV13 and PPSV23 for adults with immunocompromising conditions
  Use of PCV13 and PPSV23 Vaccine for Adults with Immunocompromising Conditions
  Source: MMWR; October 12, 2012 / 61(40);816-819
• Influenza vaccines (2012-13 season)
  Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP—United States, 2012–13 Influenza Season
  Source: MMWR; August 17, 2012 / 61(32);613-618
• Tdap for adults age 65 and older
  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012
  Source: MMWR; June 28, 2012 / 61(25);468-470
• Licensure of PCV13 for adults age 50 and older
  Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
  Source: MMWR; June 1, 2012 / 61(21);394-395
• New framework (GRADE) for development of evidence-based recommendations
  New Framework (GRADE) for Development of Evidence-Based Recommendations by the ACIP
  Source: MMWR; May 11, 2012 / 61(18);327-327
• VariZIG for postexposure prophylaxis of varicella
  FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella
  Source: MMWR; March 30, 2012 / 61(12);212-212

Top of Page

2011

• Hepatitis B vaccine in adults with diabetes
  Policy Note: Use of Hepatitis B Vaccine in Adults with Diabetes Mellitus
  Source: MMWR; December 23, 2011 / 60(50);1709-11
• Use of HPV4 in males
  Policy Note: Recommendations on Use of Quadrivalent HPV in Males—ACIP, 2011
  Source: MMWR; December 23, 2011 / 60(50);1705-8
• Health care personnel immunization
  Immunization of Health-Care Personnel: Recommendations of ACIP
  Source: MMWR; November 25, 2011 / 60(RR07);1-45
• Herpes Zoster vaccine (Shingles)
  Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years
  Source: MMWR; November 11, 2011 / 60(44);1528-1528
• Tdap and Td vaccines and pregnancy
  Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months—ACIP, 2011
  Source: MMWR; October 21, 2011 / 60(41);1424-1426
• Intussusception and rotavirus vaccine
  Addition of History of Intussusception as a Contraindication for Rotavirus Vaccination
  Source: MMWR; October 21, 2011 / 60(41);1427-1427
• Supplemental Meningococcal
  Recommendation of the ACIP for Use of MenACWY-D Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
  Source: MMWR; October 14, 2011 / 60(40);1391-1392
• Influenza vaccines (2011-12 season)
  Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP, 2011
  Source: MMWR; August 26, 2011 / 60(33);1128-1132
• Meningococcal conjugate vaccine
  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease—ACIP, 2011
  Source: MMWR; August 5, 2011 / 60(30);1391-1392
• Booster dose of JE vaccine
  Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine—ACIP, 2011
  Source: MMWR; May 27, 2011 / 60(20);661-663
• JE vaccine for children
  Update on Japanese Encephalitis Vaccine for Children—United States, May 2011
  Source: MMWR; May 27, 2011 / 60(20);664-665
• General recommendations
  General Recommendations on Immunization: Recommendations of the ACIP
  Source: MMWR; January 28, 2011 / 60(RR02);1-60
• Meningococcal Conjugate vaccine
  Updated Recommendations for Use of Meningococcal Conjugate Vaccines—ACIP, 2010
  Source: MMWR; January 28, 2011 / 60(03);72-76
• Influenza (Antiviral)
  Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of ACIP
  Source: MMWR; January 21, 2011 / 60(RR01);1-24
• Tdap vaccine
  Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Accellular Pertussis (Tdap) Vaccine from the ACIP, 2010
  Source: MMWR; January 14, 2011 / 60(01);13-15

Top of Page

2010

• Pneumococcal (PCV13 and PPSV23) vaccine (infants & children)
  Prevention of Pneumococcal Disease Among Infants and Children—Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
  Source: MMWR; December 10, 2010 / 59(RR11);1-18
• Pneumococcal (PPSV23) vaccine (adults)
  Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using PPSV23
  Source: MMWR; September 3, 2010 / 59(34);1102-1106
• Afluria influenza vaccine (2010-2011 season)
  Update: Recommendations of ACIP Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
  Source: MMWR; August 13, 2010 /59(31);989-992
• Influenza (and H1N1) vaccine
  Prevention and Control of Influenza with Vaccines
  Source: MMWR; August 6, 2010 /59(RR08);1-62
• Yellow Fever vaccine
  Yellow Fever Vaccine: Recommendations of the ACIP
  Source: MMWR; July 30, 2010 / 59(RR07);1-27
• Anthrax vaccine
  Use of Anthrax Vaccine in the United States
  Source: MMWR; July 23, 2010 / 59(RR06);1-30
• Human Papillomavirus (HPV2 and HPV4) vaccine
  • Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the ACIP
    Source: MMWR; May 28, 2010 / 59(20);626-629
  • Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the ACIP
    Source: MMWR; May 28, 2010 / 59(20);630-632
• Measles, Mumps, Rubella and Varicella (MMRV) vaccine
  Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine Recommendations of the ACIP
  Source: MMWR; May 7, 2010 / 59(RR03);1-12
• Influenza vaccine (Fluzone high-dose)
  Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use—United States, 2010
  Source: MMWR; April 30, 2010 / 59(16);485-486
• Rabies vaccine
  Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies Recommendations of the ACIP
  Source: MMWR; March 19, 2010 / 59(RR02);1-9
• Meningococcal Conjugate vaccine (Menveo)
  Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use—ACIP, 2010
  Source: MMWR; March 12, 2010 / 59(09);273
• 13-Valent Pneumococcal Conjugate vaccine (PCV13)
  Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children—ACIP, 2010
  Source: MMWR; March 12, 2010 / 59(09);258-261
• Japanese Encephalitis vaccines
  Japanese Encephalitis Vaccines Recommendations of the ACIP
  Source: MMWR; March 12, 2010 / 59(RR01);1-27

Top of Page

2009

• Influenza A (H1N1) vaccine (2009)
  Use of Influenza A (H1N1) 2009 Monovalent Vaccine: Recommendations of the ACIP, 2009
  Source: MMWR; August 21, 2009 / 58(Early Release);1-8
• Influenza vaccines (2009)
  Prevention and Control of Influenza: Recommendations of ACIP, 2009
  Source: MMWR; July 31, 2009 / 58(RR08);1-52
• Rotavirus vaccine
  Prevention of Rotavirus Gastroenteritis Among Infants and Children Recommendations of the ACIP
  Source: MMWR; February 6, 2009 / 58(RR02);1-25

2008

• Tdap vaccine and pregnancy
  Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants
  Source: MMWR; May 30, 2008 / 57(04);1-47,51
  • Appendix A – Summary
  • Appendix B – Abbreviations Used in This Report
• Herpes Zoster (Shingles) vaccine
  Prevention of Herpes Zoster: Recommendations of the ACIP
  Source: MMWR; May 15, 2008 / 57(Early Release);1-30

2007

• Varicella vaccines
  Prevention of Varicella: Recommendations of the ACIP
  Source: MMWR; June 22, 2007 / 56(RR04);1-40
• HPV vaccine
  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the ACIP
  Source: MMWR; March 12, 2007 / 56(Early Release);1-24

Top of Page

2006

• Tdap vaccine (adults)
  Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
  Source: MMWR; December 15, 2006 / 55(RR17);1-33
• Hepatitis B vaccine (adults)
  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
  Source: MMWR; December 8, 2006 / 55(RR16);1-25
• Rotavirus vaccine
  Prevention of Rotavirus Gastroenteritis Among Infants and Children
  Source: MMWR; August 11, 2006 / 55(RR12);1-13
• Hepatitis A vaccine (children)
  Prevention of Hepatitis A Through Active or Passive Immunization
  Source: MMWR; May 19, 2006 / 55(RR07);1-23
• Tdap vaccine (adolescents)
  Preventing Tdap Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
  Source: MMWR; February 23, 2006 / 55(Early Release)1-34

Top of Page

2005

• Hepatitis B vaccine
  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
  Source: MMWR; December 23, 2005 / 54(RR16);1-23

Top of Page